|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT02322008 |
|
Date of registration:
|
17/12/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice
|
|
Scientific title:
|
Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice |
|
Date of first enrolment:
|
September 2009 |
|
Target sample size:
|
1035 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT02322008 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Retrospective
|
|
Phase:
|
N/A
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- CD or UC, treated with anti-TNF
Exclusion Criteria:
- Missing data
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Ulcerative Colitis
|
|
Crohn's Disease
|
|
Inflammatory Bowel Disease
|
|
Intervention(s)
|
|
Biological: infliximab and adalimumab
|
|
Primary Outcome(s)
|
|
3-step scale
[Time Frame: 22 weeks]
|
|
Secondary ID(s)
|
|
Anti-TNF, IBD
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|